Clinical Trial Update: Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating predictive parameters for the efficacy of the sitagliptin and metformin combination in diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin/metformin (sitagliptin/metformin)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Diabetes | Phase 4 | Status: COMPLETED